July 9 (Reuters) - Medison Biotech:
* MEDISON BIOTECH - COMMENTED ON RECENT DISCLOSURE BY KNIGHT THAT IT INTENDS TO MAKE A NORMAL COURSE ISSUER BID
* MEDISON BIOTECH SAYS MEDISON DOES NOT INTEND TO PARTICIPATE IN KNIGHT NCIB & SELL ANY OF ITS SHARES